Weight-loss drug reduces risk of death for patients with heart failure, trial finds (IMAGE)
Caption
“This drug is reversing the abnormal properties of the heart brought on by obesity,” said researcher Christopher Kramer, MD, of UVA Health. “There is much more to these drugs than weight loss alone.”
Credit
Dan Addison | UVA Communications
Usage Restrictions
May be used to accompany news coverage of the SUMMIT findings. All other uses require express written permission from UVA Health.
License
Original content